About
Basic Data Updated:
1 month agoThe Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 cr and a paid-up capital of Rs 3.50 cr.
The Corporate currently has active open charges totaling ₹1.72 cr.
Srinivas Lagisetty, Babu Julapalli, and Madhavaram Rao serve as directors at the Company.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U51101TG2014PTC096702 |
| Company No. | 096702 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 05 Dec 2014 |
| Date of AGM | 30 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Financials of Curewin-Hylico Pharma Private Limited
Curewin-Hylico Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 12.18% decrease. The company also saw a substantial improvement in profitability, with a 153.07% increase in profit. The company's net worth Soared by an impressive increase of 70.97%.
Corporate Structure
Unlock access to Curewin-Hylico Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Curewin-Hylico Pharma Private Limited
Unlock and access historical data on people associated with Curewin-Hylico Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 19 Mar 2022 | ₹1.00 Cr | Open |
Hdfc Bank Limited Creation Date: 19 Jan 2022 | ₹2.20 M | Open |
Hdfc Bank Limited Creation Date: 04 Sep 2020 | ₹5.00 M | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Curewin-Hylico Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curewin-Hylico Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
1 year 8 months Recent activity within the organization
Annual General Meeting
Curewin-Hylico Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
30 Sep 2023Balance Sheet
Curewin-Hylico Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Charges
A charge with Axis Bank Limited amounted to Rs. 1.00 cr with Charge ID 100554590 was registered on 19 Mar 2022.
19 Mar 2022Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.22 cr with Charge ID 100534993 was registered on 19 Jan 2022.
19 Jan 2022Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.50 cr with Charge ID 100374366 was registered on 04 Sep 2020.
04 Sep 2020
Frequently asked questions
What is the Incorporation or founding date of Curewin-Hylico Pharma Private Limited?
